KRYS vs PEP · P/E 46, rev $235.6M vs P/E 22, rev $43.62B
Krystal Biotech Inc (KRYS) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Laguarta.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Latest reported PEP revenue for 2026-06-13 was $43.62B. Net income was $5.31B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the KRYS and PEP stock pages for the full models.
Not investment advice.